CD274 and neoplasm: We are pleased to present our latest analyses, showing that multiple immunofluorescence (MIF) can be used in large multicenter clinical trials to define the prognostic/predictive value of programmed death‐ligand 1 (PD‐L1) by concomitantly and precisely assessing its expression and spatial distribution in the tumour tissue, outperforming classical immunohistochemistry (IHC).